Original article. Efficacy of intravenous dexamethasone for the prevention of vomiting associated with intrathecal chemotherapy and ketamine sedation in children: a randomized, double-blinded, crossover, placebocontrolled trial
Background: Chemotherapy-induced nausea and vomiting remains a significant problem for children with leukemia. There is limited evidence to support using prophylactic antiemetic prior to the administration of intrathecal chemotherapy.
Objective: Determine whether vomiting and nausea associated with intravenous ketamine and intrathecal chemotherapy may be reduced by the addition of prophylactic dexamethasone in children.
Method:A randomized, double-blinded, crossover, placebo-controlled trial was completed in 33 children receiving intrathecal chemotherapy with methotrexate and ketamine sedation at Pharmongkutklao Hospital. Patients were randomly assigned in a double-blinded fashion to receive one of two interventions during the first period, either an infusion of normal saline or intravenous dexamethasone at 0.25 mg/kg/dose. Each patient acted as his or her own control, and each patient was studied at two time-points.
Results: Period effect, sequence effect, and carry over effect were not demonstrated. The absolute risk reduction of vomiting was significantly greater after infusion of dexamethasone than after placebo at 33.3 % (p=0.02). The number needed to treat was three to prevent one episode of vomiting. Fifteen patients in the treatment group reported nausea versus 26 patients in the placebo group (p= 0.007). In the group of patients treated with dexamethasone, five required antiemetic vs. 16 of those receiving placebo (p=0.02). There was no complication from dexamethasone.
Conclusion: Intravenous dexamethasone reduced vomiting associated with intrathecal chemotherapy and ketamine sedation, without significant side-effects. It may be recommended a reasonable option before intrathecal chemotherapy
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Onciu M. Acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009; 23:655-74.
2. Pui CH Campana D Pei D Bowman WP Sandlund JT Kaste SC et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation N Engl J Med. 2009; 360:2730-41.
3. Holdsworth MT Raisch DW Winter SS Chavez CM. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron. Support Care Cancer. 1998; 6:132-8.
4. Langston WT Wathen JE Roback M Bajaj L. Effect of ondansetron on the incidence of vomiting associated with ketamine sedation in children: a double-blind randomized placebo-controlled trial. Ann Emerg Med. 2008; 52:30-4.
5. Jordan K Kasper C Schmoll HJ. Chemotherapyinduced nausea and vomiting: Current and new standards in the antiemetic prophylaxis and treatment. Eur J Cancer. 2005; 41:199-205.
6. Holdsworth MT Raisch DW Duncan MH Chavez CM Leasure MM. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia. Ann Pharmacother. 1995; 29:16-21.
7. Jones B Kenward MG. Design and Analysis of Cross- Over Trials. 1st ed. Chapman & Hall/CRC. 1989; p. 340.
8. Senn SS. Cross-over Trials in Clinical Research. 2nd ed. Chichester:John Wiley & Sons. 2002; p. 345.
9. Jayabose S Levendoglu-Tugal O Giamelli J Grodin W Cohn M Sandoval C et al. Intravenous anesthesia with propofol for painful procedures in children with cancer. J Pediatr Hematol Oncol. 2001; 23:290-3.
10. Larsson S Argeirsson B Magnusson J. Propofolfentanyl anesthesia compared to thiopental-halothane with special reference to recovery and vomiting after pediatric strabismus surgery. Acta Anaesthsiol Scand. 1992; 36:182-6.
11. Martin TM Nicholson SC Bargas MS. Propofol anesthesia reduces emesis and airway obstruction in pediatric outpatients. Anesth Analg. 1993; 76:144-8.
12. Nagel K Willan AR Lappan J Korz L Buckley N Barr RD. Pediatric oncology sedation trial (POST): A double-blind randomized study. Pediatr Blood Cancer. 2008; 51:634-8.
13. Parker RI Prakash D Mahan RA Giugliano DM Atlas MP. Randomized double-blind crossover placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children. J Pediatr Hematol Oncol. 2001; 23: 578-81.
14. Pitetti RD Singh S Peirce MC. Safe and efficacious use of procedural sedation and analgesia by non anesthesiologists in a pediatric emergency department. Arch Pediatr Adolesc Med. 2003; 157:1090-6.
15. Aapro MS Alberts DS. Dexamethasone as an antiemetic in patients treated with cisplatin. N Engl J Med. 1981; 305:520.
16. Markman M Sheidler V Ettinger DS Quaskey SA Mellits ED. Antiemetic efficacy of dexamethasone. Randomized double-blind crossover study with prochlorperazine in patients receiving cancer chemotherapy. N Engl J Med. 1984; 311:549-52.
17. Holte K Kehlet H. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg. 2000; 195: 694-712.
18. Olver I Clark-Snow RA Ballatori E Espersen BT Bria E Jordan K. Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential. Support Care Cancer. 2011; 19:33-6.
19. Bisgaard T Klarskov B Kehlet H Rosenberg J. Preoperative dexamethasone improves surgical outcome after laparoscopic cholecystectomy: a randomized double-blind placebo-controlled trial. Ann Surg. 2003; 238:651-60.
20. Apfel CC Korttila K Abdalla M Kerger H Turan A Vedder I et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004; 350:2441-51.
21. Subramaniam B Madan R Sadhasivam S Sennaraj B Tamilselvan P Rajeshwari S et al. Dexamethasone is a cost-efective alternative to ondansetron in preventing PONV after paediatric strabismus repair. Br J Anaesth. 2001; 86:84-9.
22. Hesketh PJ Kris MG Grunberg SM Beck T Hainsworth JD Harker G et al. Proposal for classifying the acute emetogenicity of cancer chemotherapy. J Clin Oncol. 1997; 15:103-9.
23. Tanihata S Oda S Nakai S Uchiyama T. Antiemetic effect of dexamethasone on cisplatin-induced early and delayed emesis in the pigeon. Eur J Pharmacol. 2004; 484:311-21.
24. Green SM Krauss B. Clinical practice guideline for emergency department ketamine dissociative sedation in children. Ann Emerg Med. 2004; 44:460-71.
25. Janinis J Giannakakis T Athanasiades A Fountzilas G Bafaloukos D Kosmidis P et al. A randomized open-label parallelgroup study comparing ondansetron with ondansetron plus dexamethasone in patients with metastatic breast cancer receiving high-dose epirubicin. A Hellenic Cooperative Oncology Group study. Tumori. 2000; 86:37-41.
26. Lopez-Olaondo L Carrascosa F Pueyo FJ Monedero P Busto N Saez A. Combination of ondansetron and dexamethasone in the prophylaxis of postoperative nausea and vomiting. Br J Anaesth. 1996; 76: 835-40.
27. Henzi I Walder B Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2000; 90:186-94.
28. Madan R Bhatia A Chakithandy S Subramaniam R Rammohan G Deshpande S et al. Prophylactic dexamethasone for postoperative nausea and vomiting in pediatric strabismus surgery: a dose ranging and safety evaluation study. Anesth Analg. 2005; 100:1622-6.
29. Liechti M Feurer R Gross D Schmitz A Stutz K Gerber A et al. Prevention of postoperative nausea and vomiting in children following adenotonsillectomy using tropisetron with or without low-dose dexamethasone. J Anesth. 2007; 21:311-6.
30. Mathew PJ Madan R Subramaniam R Bhatia A Mala CG Soodan A et al. Efficacy of low-dose dexamethasone for preventing postoperative nausea and vomiting following strabismus repair in children. Anaesth Intensive Care. 2004; 32:372-6.
31. Ng WL Della-Fiorentina SA. The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapya retrospective audit. Eur J Cancer Care (Engl). 2010; 19:403-7.